Genmab A/S/ DK0010272202 /
| 4/25/2025 4:59:45 PM | Chg. +8.00 | Volume | Bid4:59:45 PM | Ask4:59:45 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1,350.00DKK | +0.60% | 70,591 Turnover: 49.65 mill. |
-Bid Size: - | -Ask Size: - | 89.15 bill.DKK | - | 11.02 |
Fundamentals
| FY 2024 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 122.21 DKK | 83.39% |
| EPS Diluted: | - DKK | 83.82% |
| Revenues per Share: | 325.23 DKK | 30.44% |
| Book Value per Share: | 554.44 DKK | 15.90% |
| Cash Flow per Share: | 11.65 DKK | -89.57% |
| Dividend per Share: | - DKK | - |
| Total | in mill. | |
| Revenues: | 21,526.00 DKK | 30.67% |
| Net Income: | 7,844.00 DKK | 80.24% |
| Operating Cash Flow: | 771.00 DKK | - |
| Cash and Cash Equivalents: | 9,858.00 DKK | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 11.02 | 12.21 |
| P/S Ratio: | 4.14 | 4.59 |
| P/BV ratio: | 2.43 | 2.69 |
| P/CF Ratio: | 115.63 | 128.13 |
| PEG: | 0.13 | 0.15 |
| Earnings Yield: | 9.07% | 8.19% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 89.15 bill. DKK | 98.78 bill. DKK |
| Free Float Market Cap.: | - DKK | - DKK |
| Market Cap. / Employee: | 33.24 mill. DKK | 36.83 mill. DKK |
| Shares Outstanding: | 66.19 mill. | |
Profitability
| Gross Profit Margin: | 95.42% |
| EBIT Margin: | 31.14% |
| Net Profit Margin: | 36.44% |
| Return on Equity: | 21.38% |
| Return on Assets: | 17.12% |
Financial Strength
| Liquidity I / Cash Ratio: | 185.72% |
| Liquidity II / Quick Ratio: | 309.87% |
| Liquidity III / Current Ratio: | 524.76% |
| Debt / Equity Ratio: | 24.84% |
| Dynam. Debt / Equity Ratio: | 1,182.10% |
Efficiency
| Employees: | 2,682 |
| Personal Expenses / Employee: | - DKK |
| Revenues / Employee: | 8,026,099.93 DKK |
| Net Income / Employee: | 2,924,683.07 DKK |
| Total Assets / Employee: | 17,080,909.77 DKK |
| * Fiscal Year End: | 12/31/2024 |
| Accounting Standard: | IFRS |
| Currency: | DKK |
